The multifaceted biology of PCSK9

NG Seidah, A Prat - Endocrine reviews, 2022 - academic.oup.com
This article reviews the discovery of PCSK9, its structure–function characteristics, and its
presently known and proposed novel biological functions. The major critical function of …

[HTML][HTML] The mucosal immune system of teleost fish

I Salinas - Biology, 2015 - mdpi.com
Teleost fish possess an adaptive immune system associated with each of their mucosal
body surfaces. Evidence obtained from mucosal vaccination and mucosal infection studies …

[HTML][HTML] PCSK9 inhibitors: a new era of lipid lowering therapy

R Chaudhary, J Garg, N Shah… - World journal of …, 2017 - ncbi.nlm.nih.gov
Hyperlipidemia is a well-established risk factor for developing cardiovascular disease
(CVD). The recent American College of Cardiology and American Heart Association …

PCSK9: a key modulator of cardiovascular health

NG Seidah, Z Awan, M Chrétien, M Mbikay - Circulation research, 2014 - Am Heart Assoc
Since the discovery of proprotein convertase subtilisin kexin 9 (PCSK9) in 2003, this PC has
attracted a lot of attention from the scientific community and pharmaceutical companies …

[HTML][HTML] Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial

H Bjermo, D Iggman, J Kullberg, I Dahlman… - The American journal of …, 2012 - Elsevier
Background: Replacing SFAs with vegetable PUFAs has cardiometabolic benefits, but the
effects on liver fat are unknown. Increased dietary n-6 PUFAs have, however, also been …

[HTML][HTML] The PCSK9 decade: thematic review series: new lipid and lipoprotein targets for the treatment of cardiometabolic diseases

G Lambert, B Sjouke, B Choque, JJP Kastelein… - Journal of lipid …, 2012 - ASBMB
PCSK9 proprotein convertase subtilisin/kexin type (PCSK9) is a crucial protein in LDL
cholesterol (LDL-C) metabolism by virtue of its pivotal role in the degradation of the LDL …

MicroRNA-148a regulates LDL receptor and ABCA1 expression to control circulating lipoprotein levels

L Goedeke, N Rotllan, A Canfrán-Duque, JF Aranda… - Nature medicine, 2015 - nature.com
The hepatic low-density lipoprotein receptor (LDLR) pathway is essential for clearing
circulating LDL cholesterol (LDL-C). Whereas the transcriptional regulation of LDLR is well …

[HTML][HTML] Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and inlivers of parabiotic mice

TA Lagace, DE Curtis, R Garuti… - The Journal of …, 2006 - Am Soc Clin Investig
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a member of the proteinase K
subfamily of subtilases that reduces the number of LDL receptors (LDLRs) in liver through …

Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype

KN Maxwell, JL Breslow - Proceedings of the National …, 2004 - National Acad Sciences
Proprotein convertase subtilisin kexin 9 (Pcsk9) is a subtilisin serine protease with a putative
role in cholesterol metabolism. Pcsk9 expression is down-regulated by dietary cholesterol …

Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9

S Rashid, DE Curtis, R Garuti… - Proceedings of the …, 2005 - National Acad Sciences
PCSK9 encodes proprotein convertase subtilisin/kexin type 9a (PCSK9), a member of the
proteinase K subfamily of subtilases. Missense mutations in PCSK9 cause an autosomal …